This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Treatment

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The optimal treatment of acute cardioembolic stroke represents a balance between reducing early recurrence of embolism and of precipitating secondary brain haemorrhage. About 12% of patients with an acute cardioembolic stroke have a recurrence within 2 weeks; the figure rises to about 20% if there is an associated atrial fibrillation.

Intravenous heparin should be given 48 hours after the event. The delay is advised because of the propensity of cardioembolic strokes to undergo secondary haemorrhagic transformation. Anticoagulation should be delayed until 7-10 days following the event if there are severe neurological deficits.

Antibiotics per se, are associated with reduced recurrence when the suspicion is infective endocarditis.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.